Navigation Links
Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
Date:10/23/2007

COLUMBUS, Ga., Oct. 23 /PRNewswire-FirstCall/ -- Aflac Incorporated today reported its third quarter results.

Reflecting a weaker yen to the dollar, total revenues rose 5.1% to $3.9 billion during the third quarter of 2007, compared with $3.7 billion in the third quarter of 2006. Net earnings were $420 million, or $.85 per diluted share, compared with $367 million, or $.73 per share, a year ago. Net earnings included realized investment gains of $1 million, or nil per diluted share, compared with $7 million, or $.01 per diluted share in the third quarter of 2006. Net earnings in the third quarter of 2007 also included a gain of $2 million, or nil per diluted share, from the change in fair value of the interest rate component of the cross-currency swaps related to the company's senior notes, as required by SFAS 133. In the third quarter of 2006, the impact from SFAS 133 reduced net earnings by $3 million, or nil per diluted share.

We believe that an analysis of operating earnings, a non-GAAP financial measure, is vitally important to an understanding of Aflac's underlying profitability drivers. We define operating earnings as the profits we derive from our operations before realized investment gains and losses, the impact from SFAS 133, and nonrecurring items. Management uses operating earnings to evaluate the financial performance of Aflac's insurance operations because realized gains and losses, the impact from SFAS 133, and nonrecurring items tend to be driven by general economic conditions and events, and therefore may obscure the underlying fundamentals and trends in Aflac's insurance operations.

Furthermore, because a significant portion of our business is in Japan, where our functional currency is the Japanese yen, we believe it is equally important to understand the impact on operating earnings from translating yen into dollars. We translate Aflac Japan's yen-denominated income statement from yen into dollars using an average exchange
'/>"/>

SOURCE Aflac Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingme...iorsinthegreaterLongBeachareathankstoFaithInAction...denceatHome(IAH),adivisionofSCANHealthPlan.Formore...fvolunteerstodeliverwarmThanksgivingmealstoseniors...thLosAngelesandsurroundingcities. ,, "Ourwarmho...
(Date:11/25/2009)...ANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuali...er Spare the Air Alert forThursday,N...elogsoranyothersolidfuel,bothindoorsandoutdoors. ,...rqualitytomorrow,"saidJackBroadbent,executiveoffic...espectthehealthoftheirneighborsandfellowcommunitym...
(Date:11/25/2009)...hers have found evidence of a statistically signif...ng patients whose estrogen receptor (ER)-positive ...pha; at serine-118 (ER-alpha S118-P), according to...5 in the Journal of the National Cancer Institute...resistant to tamoxifen. Preclinical studies have s...
(Date:11/25/2009)... follow-up period was too short to draw definite c... Nov. 25 (HealthDay News) -- In diabetic patients ...e no difference in outcomes at one year whether pa...stenting, British researchers report. , Bypass ...ic patients with coronary artery disease. However,...
(Date:11/25/2009)...forgetfulness could lead mothers to overlook neede...25 (HealthDay News) -- A mother,s depression can w...und. , Their six-month study of 262 black mothe...thers had more depressive symptoms had more freque... fewer depressive symptoms had less frequent asthm...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2
... 18 Sales leaders and,organizations that regularl...e art of motivating their sales representatives. O... sales personnel can use the key findings,discover... Best Practices, LLC conducted this benchmark stud...
...e following is being,issued by the American Hospit...nd Coalition of Full Service Community Hospitals:,... self-referral and the,conflict of interest it cre...ssed a ban on physician self-referral to,hospitals...
...ght now, about half of all people who take medicin...it. And doctors have no definitive way to predict ...iety prescription they write. , But a University...ing the connection between brain activity, genetic...
...8 QMed, Inc.,(Nasdaq: QMED ) today announced tha...ter dated April 14, 2008, notifying the Company th...e 4350(i)(1)(A) due to its,failure to comply with ...eting the financing in violation of shareholder,ap...
... diminished depression almost as much as drug trea...s) -- Talk therapy can help treat depression sympt... Japanese researchers who reviewed the results of ... was supportive expressive group therapy, in which...
...foods have staying power,according to a new report...he U.S. The soy food and beverage market topped $2...snack bar and soymilk products. Sales of soy,foods...gh 2012, rounding out at $3 billion., Having been...
Other Medicine News:Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:High anxiety? 2Health News:High anxiety? 3Health News:High anxiety? 4Health News:QMed, Inc. Receives NASDAQ Delisting Letter 2Health News:QMed, Inc. Receives NASDAQ Delisting Letter 3Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2Health News:Soy Foods Beat Out Fresh Fish and Meat for 'Best New Products Tried By Consumers' While Demand and Profits Continue to Grow 2
(Date:11/25/2009)...irstCall/--AmericanScientificResourcesInc.(PinkShe...haveopenedaregionalmarketingandproductionmanagemen...urealocationabroad,providinganessentialgatewayfort...andsafetyproductsforchildrenandadultstobedistribut...ryinthestateofOhiowheretheywillalsobeabletodosubco...
(Date:11/25/2009)...5/PRNewswire/-- FromNovember16-18,Phonak,theleadin...dthesecondeditionoftheHearingCareforAdultsConferen...heconferencebroughttogetherleadingexpertsinagingan...nswhoworkeverydaywitholderpeoplewithhearinglossfor...researchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 1Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 3Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: